Johanna Friedl-Naderer, Chief Commercial Officer at Dyne Therapeutics, Inc. (DYN), sold 1,038 shares at $13.27 ($14K) on 2025-09-04, disclosed to the SEC on 2025-09-08.
Scheduled sale ($14k) by Chief Commercial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.27 | 894 | $12K | 86.0% |
| 2 | $13.41 | 144 | $2K | 14.0% |
| Total | $13.29 avg | 1,038 | $14K | 100% |
| Filing → |
| DYN | SELL | 2026-06-17 | $3K | — | Filing → |
| DYN | SELL | 2026-05-14 | $4K | — | Filing → |
| DYN | SELL | 2026-03-06 | $2K | — | Filing → |